denovoMATRIX logo

denovoMATRIX

Enabling biology in vitro

7 employees · est. 2018 · Dresden, Germany

VS
Zafrens logo

Zafrens

Opening doors to new insights at the interface of biology, chemistry and engineering

30 employees · est. 2022 · San Diego, United States

denovoMATRIX is the older company (2018 vs 2022); Zafrens is the larger of the two.

Side-by-Side Comparison

denovoMATRIX Zafrens
Founded
2018 older 2022
Headquarters
Dresden, Germany San Diego, United States
Employees
7 30 larger
Industry
Biotechnology, Health and Wellness, Life Sciences Not tracked yet
Funding Stage
Seed Series A
Total Funding
Not tracked yet $31.00M
Funding Rounds
1 2
Services
Not tracked yet Advanced mRNA Sequencing, High-Throughput Screening with Z-Screen, Simultaneous Phenotypic and Molecular Assays, Scientific Discoveries through Large Perturbation Libraries
Target Customers
Not tracked yet Pharmaceutical Companies, Biotechnology Research Firms, Academic Research Institutions, Drug Discovery Scientists
Taxonomy
Biotech, Combinatorial Screening, Biomaterials, Cell-based Therapies, Clean Meat Industry, Cell Culture, Life Sciences, Medical Applications Therapeutics, Ultra-high Throughput Platform, Cell Isolation, Cell Culture, Cell Imaging, Cell Sequencing, Molecular Profiling, Cell Phenotype Characterization, Drug Discovery, Life Sciences Products, Bioinformatics, Cell Biology, Chemistry-engineering Interface
Website
denovomatrix.com zafrens.com
denovoMATRIX logo

About denovoMATRIX

denovoMATRIX is a German biotechnology startup founded in 2018, with the slogan "Enabling biology in vitro." The company's primary focus is on offering a combinatorial screening matrix product for life science researchers. This product enables researchers to identify the best tailor-made biomaterial...

Zafrens logo

About Zafrens

Zafrens, founded in 2022, is a pioneering therapeutics company headquartered in the United States. The company's slogan, "Opening doors to new insights at the interface of biology, chemistry and engineering," aptly reflects their vision of redefining drug discovery processes. Zafrens has developed...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at denovoMATRIX and Zafrens — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at denovoMATRIX and Zafrens — by email.

Frequently Asked Questions

denovoMATRIX — Enabling biology in vitro. Zafrens — Opening doors to new insights at the interface of biology, chemistry and engineering. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
denovoMATRIX has raised undisclosed funding while Zafrens has raised $31.00M.
denovoMATRIX and Zafrens operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare denovoMATRIX with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy